Table of Contents Table of Contents
Previous Page  1502 / 2894 Next Page
Information
Show Menu
Previous Page 1502 / 2894 Next Page
Page Background

22. Fraser CL, Sarnacki P: Na

+

/K

+

ATPase pump

function in male rat brain synaptosomes is different

from that of females. Am J Physiol 257:E284, 1989.

23. Black RM: Disorders of serum sodium and serum

potassium.

In

Rippe JM, Irwin RS, Alpert JS, et al

(eds): Intensive Care Medicine. Boston, Little,

Brown, 1985.

24. Sarnaik AP, Meert K, Hackbarth R, et al: Manage-

ment of hyponatremic seizures in children with

hypertonic saline: A safe and effective strategy. Crit

Care Med 19:758, 1991.

25. Oh M, Carrol H: Disorders of sodium metabolism:

Hypernatremia and hyponatremia. Crit Care Med

20:94, 1992.

26. Perez GO, Oster JR, Robertson GL: Severe hyperna-

tremia with impaired thirst. Am J Nephrol 9:421,

1989.

27. Illner HP, Cunningham JN, Shires GT: Red blood

cell sodium content and permeability changes in

hemorrhagic shock. Am J Surg 143:349, 1982.

28. Coran AG: Perioperative care of the pediatric

patient. Surg Ann 23(Pt 1)31, 1991.

29. Brown MJ, Brown DL, Murphy MB: Hypokalemia

from

b

2 receptor stimulation by circulating epine­

phrine. N Engl J Med 309:1414, 1983.

30. Vincent HH, Boomsma F, Man in’t Veld AJ, et al:

Effects of selective and nonselective beta agonists

on plasma potassium and norepinephrine. J Cardio-

vasc Pharmacol 6:107, 1984.

31. Papademetrious V, Fletcher R, Khatri IM, et al:

Diuretic-induced hypokalemia in uncomplicated

systemic hypertension: Effect of plasma potassium

correction on cardiac arrhythmias. Am J Cardiol

52:1017, 1983.

32. Papademetrious V, Burris J, Kukish SIM, et al: Effec-

tiveness of potassium chloride or triamterene in

thiazide hypokalemia. Arch Intern Med 145:1986,

1985.

33. DeFronzo RA: Intravenous potassium chloride

therapy. JAMA 245:2446, 1981.

34. Solomon RJ, Katz JD: Disturbances of potassium

homeostasis.

In

Stoelting RK (ed). Advances in

Anesthesia vol 3. Chicago, Year Book Medical

Publishers, 1986.

35. AllonM, Takeshian A, Shanklin N: Effect of insulin-

plus-glucose infusion with or without epinephrine

or fasting hyperkalemia. Kidney Int 43:212, 1993.

36. Holick MF, Krane SM, Potts JT: Calcium, phospho-

rus, and bone metabolism: Calcium-regulating hor-

mones.

In

Isselbacher KJ, Braunwald E, Wilson JD, et

al (eds): Harrison’s Principles of Internal Medicine,

13th ed. New York, McGraw-Hill, 1994, p 2139.

37. Vivien B, Langeron O, Morrell E, et al: Early hypo-

calcemia in severe trauma. Crit Care Med 33:1946,

2005.

38. Harris MNE, Crowther A, Jupp RA, et al: Magne-

sium and coronary revascularization. Br J Anesth

60:779, 1988.

39. Kamalanathan S, Vijayan A: Fluid and electrolyte

management.

In

Cooper DH, Krainik AJ, Lubner SJ,

et al (eds): The Washington Manual of Medical The­

rapeutics, 32nd ed. Philadelphia, Lippincott

Williams & Wilkins, 2007, p 89.

40. James MFM: Clinical use of magnesium infusions

in anesthesia. Anesth Analg 74:129, 1992.

41. Cross HS, Debiec H, Peterlik M: Mechanism and

regulation of intestinal phosphate reabsorption.

Miner Electrolyte Metab 16:115, 1990.

42. Rhoades RA, Tanner GA: Medical Physiology.

Boston, Little, Brown, 1995.

43. Cohena J, Koganb A, Saharb G, et al: Hypo­

phosphatemia following open heart surgery: Inci-

dence and consequences. Eur J Cardiothorac Surg

26:306, 2004.

44. Levinsky NG: Acidosis and alkalosis.

In

Isselbacher

KJ, Braunwald E, Wilson JD, et al (eds): Harrison’s

Principles of Internal Medicine, 13th ed. New York,

McGraw-Hill, 1994, p 255.

45. Drummond JC, Moore SS: The influence of dex-

trose administration on neurologic outcome after

temporary spinal cord ischemia in the rabbit. Anes-

thesiology 70:64, 1989.

46. Sieber FE, Traystman RJ: Special issues: Glucose

and the brain. Crit Care Med 20:104, 1992.

47. Stagnaro-Green A: Perioperative glucose control:

Does it really matter? Mt Sinai J Med 58:299,

1991.

48. McMurry JF Jr: Wound healing with diabetes melli-

tus: Better glucose control for better wound healing

in diabetes. Surg Clin North Am 64:769, 1984.

49. Welborn LG, McGill WA, Hannallah RS, et al: Perio-

perative blood glucose concentrations in pediatric

outpatients. Anesthesiology 65:543, 1986.

50. Welborn LG, McGill WA, Hannallah RS, et al:

Glucose concentrations for routine intravenous

infusion in pediatric outpatient surgery. Anesthe-

siology 67:427, 1987.

51. Degoute CS, Ray MJ, Manchon M, et al: Intraopera-

tive glucose infusion and blood lactate: Endocrine

and metabolic relationships during abdominal

aortic surgery. Anesthesiology 71:355, 1989.

52. The Carter Center of Emory University: Closing the

gap: The problem of diabetes mellitus in the United

States. Diabetes Care 8:391, 1985.

53. Nesmeth J: Type 2 diabetes in children and adoles-

cents. Pediatr Rev 105:671, 2000.

54. Foster DW: Endocrinology and metabolism.

In

Wilson JD, Braunwald E, Fauci AS, et al (eds):

Harrison’s Principles of Internal Medicine, 12th ed.

New York, McGraw-Hill, 1991, p 1743.

55. Engelgau MM, Herman WH, Smith PJ, et al: The

epidemiology of diabetes and pregnancy in the U.S.,

1988. Diabetes Care 18:1029, 1995.

56. Stewart WJ, McSweeney SM, Kellet MA, et al:

Increased risk of severe protamine reactions in

NPH insulin-dependent diabetics undergoing

cardiac catheterization. Circulation 70:788, 1984.

57. Humalog (insulin lispro) package insert. Indiana-

polis, IN, Eli Lilly, 2001.

58. Kucera ML, Graham JP: Insulin lispro, a new insulin

analog. Pharmacotherapy 18:526, 1998.

59. Dimarchi RD, Chance RE, Lon HB, et al: Prepara-

tion of an insulin with improved pharmacokinetics

relative to human insulin through consideration of

structure homology with insulin like growth factor

1. Horm Res 41(Suppl 2)93, 1994.

60. Howey DC, Bowsher RR, Brunelle RL, Woodworth

JR: Lys(B28) Pro(B29) human insulin: A rapidly

absorbed analog of human insulin. Diabetes 43:396,

1994.

61. Ciszak E, Beals JM, Frank BH, et al: Role of C-ter-

minal B-chain residues in insulin assembly: The

structure of Hexameric Lys(B28) Pro(B29) human

insulin. Structure 3:615, 1995.

62. Lantus (insulin glargine) package insert. Kansas

City, MO, Aventis Pharmaceuticals, April 2000.

63. Heinemann L, Linkeschova R, Rave K, et al: Time

action profile of the long-acting insulin analog

insulin glargine (HOE 901) in comparison with

those of NPH insulin and placebo. Diabetes Care

23:644, 2000.

64. Madsen H, Ditzel J: Changes in red blood cell

oxygen transport in diabetic pregnancy. Am J

Obstet Gynecol 143:421, 1982.

65. Kitamura A, Hoshino T: Patients with diabetic neu­

ropathy are at risk of a greater intraoperative reduc-

tion in core temperature. Anesthesiology 92:1311,

2000.

66. Tsueda K, Huang KC, Dumond SW, et al: Cardiac

sympathetic tone in anaesthetized diabetics. Can J

Anaesth 38:20, 1991.

67. Kannel W, McGee D: Diabetes and cardiovascular

disease: The Framingham Study. JAMA 241:2035,

1979.

68. Haffner SM, Lehto S, Ronnemaa T, et al: Mortality

from coronary heart disease in subjects with type 2

diabetes and in nondiabetic subjects with and

without prior myocardial infarction. N Engl J Med

339:229, 1998.

69. Schaade DS: Surgery and diabetes. Med Clin North

Am 72:1531, 1988.

70. Gavin LA: Management of diabetes mellitus during

surgery. West J Med 151:525, 1989.

71. Reissel E, Orko R, Maunuksela E, et al: Predicta-

bility of difficult laryngoscopy in patients with

long-term diabetes mellitus. Anaesthesia 43:1024,

1990.

72. Hogan K, Rusty D, Springman SR: Difficult laryn-

goscopy and diabetes mellitus. Anesth Analg

67:1162, 1988.

73. Davidson MB, Schriger DC, Peters AL, et al: A cli-

nical approach for the diagnosis of diabetes melli-

tus: An analysis using glycosylated hemoglobin

levels. JAMA 276:1246, 1996.

74. Nathan DM: Hemoglobin A

1c

: Infatuation or the

real thing? N Engl J Med 323:1062, 1990.

75. American Hospital Formulary Service: Miscella-

neous Antidiabetic Agents. Bethesda, MD, ASHP,

2000, 68.20.92 3032-41.

76. Glucophage R (metformin) product information.

Princeton, NJ, Bristol-Myers-Squibb, October 2000.

77. Watson BG, Pay DA, Williamson M, et al: Practical

closed-loop insulin infusion. Life Support Syst

3(Suppl 1)519, 1985.

78. Hirsch IB, Magill JB, Cryer PE, et al: Perioperative

management of surgical patients with diabetes

mellitus. Anesthesiology 74:346, 1991.

79. Nutt LK, O’Neil RG: Effect of elevated glucose on

endothelin-induced store-operated and non-store-

operated calcium influx in renal mesangial cells. J

Am Soc Nephrol 11:1225, 2000.

80. Marhoffer W, Stein M, Maeser D, et al: Impairment

of PMN leukocyte function and metabolic control

of diabetes. Diabetes Care 15:256, 1992.

81. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A:

Continuous intravenous insulin infusion reduces

the incidence of deep sternal wound infection in

diabetic patients after cardiac surgical procedures.

Ann Thorac Surg 67:352, 1999.

82. Rassias AJ, Marrin CA, Arruda J, et al: Insulin infu-

sion improves neutrophil function in diabetic

cardiac surgery patients. Anesth Analg 88:1011,

1999.

83. Khaodhiar L, McCowen K, Bistrian B: Perioperative

hyperglycemia, infections and risk. Curr Opin Clin

Nutr Metab Care 2:79, 1999.

84. Boyle PJ, Schwartz NS, Shah SD, et al: Plasma

glucose concentrations at the onset of hypoglyce-

mic symptoms in patients with poorly controlled

diabetes and in nondiabetics. N Engl J Med

318:1487, 1988.

85. Wasserstrum N: Issues in fluid management during

labor: General considerations. Clin Obstet Gynecol

35:505, 1992.

86. Dutton R: Current concepts in hemorrhagic shock.

Anesthesiol Clin 25:23-34, 2007.

87. AlamHB, Rhee P: New developments in fluid resus-

citation. Surg Clin North Am 87:55, 2007.

88. Shoemaker WC, Appel PL, KramHB, et al: Prospec­

tive trial of supranormal values of survivors as the­

rapeutic goals in high risk surgical patients. Chest

94:1176, 1988.

1502

Control de la anestesia

III